SecBot SecBot
144 ·Filed Nov 2, 2026

NRIX

Nurix Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonimmediate Processed14d 7h ago SEC0001950047-26-010564
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The sale is small relative to market cap and follows a pattern of routine 10b5-1 plan sales. No material impact expected; monitor for any acceleration of insider selling or changes in officer holdings.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5
Entry
$25.82
T+0 close · Nov 2, 2026 · via day close
Latest settled
−38.50%
T+5 · $15.88 · next T+20 in 15d
Vs SPY
−37.91%
α at T+5
Latest observation
−39.24%
T+8 · FF3 residual α
  1. T+0 · Nov 3 $25.82entry
  2. T+1 · 13d ago −38.23%α −39.88% · $15.95
  3. T+5 · 7d ago −38.50%α −37.91% · $15.88
  4. T+9 · todayOpen
  5. T+20 · in 15d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Christine Ring, an officer of Nurix Therapeutics, filed a Form 144 notice of intent to sell 5,786 shares of common stock, valued at approximately $284,134 based on the filing date price. The shares were acquired through the exercise of stock options on November 2, 2026, and the sale is planned for the same day. The filing also discloses prior 10b5-1 plan sales in August, September, and October 2026, indicating a pattern of routine insider selling.

Key Facts

  • Christine Ring, an officer, filed Form 144 to sell 5,786 shares of common stock.
  • Estimated sale value is $284,133.60 based on the filing date.
  • Shares were acquired via exercise of stock options on November 2, 2026.
  • Proposed sale date is November 2, 2026 (same day as filing).
  • Prior 10b5-1 plan sales occurred in August, September, and October 2026, totaling approximately $665,580.
  • The sale represents about 0.26% of the issuer's outstanding shares (based on 109,249,814 shares outstanding).
  • Market cap is $3.0 billion, making the sale value ~0.0095% of market cap.

Financial Impact

Sale of 5,786 shares valued at $284,134, representing 0.26% of outstanding shares and 0.0095% of market cap.

dilutioninsider selling

Risk Factors

  • Insider selling could signal lack of confidence if it deviates from the established 10b5-1 pattern.
  • The filing is an intent to sell; the actual sale may not occur.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
90% bullish (20 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-010564
Document: 0001950047-26-010564-index.html0001950047-26-010564
Document: 0001950047-26-010564.txt0001950047-26-010564

Track record

33 reports on NRIX

Performance horizon

4 of 6 bullish or bearish reports moved the stock their way by T+20. Best: +53.71% at T+20 after the Jun 8, 2026 report. 6 of 7 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $14.67 Now $14.73 +0.41% settles Dec 16
  2. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $15.17 Now $14.73 −2.90% settles Dec 15
  3. Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $15.41 Now $14.73 −4.41% settles Dec 15
  4. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $14.84 Now $14.73 −0.74% settles Dec 4
  5. Nov 4, 202612d ago Insider Cluster Neutral 2/10 Entry $14.84 Now $14.73 −0.74% settles Dec 4
  6. Nov 4, 202612d ago 144 Neutral 2/10 Entry $14.84 Now $14.73 −0.74% settles Dec 4
  7. Nov 3, 202613d ago 144 Neutral 2/10 Entry $15.95 Now $14.73 −7.65% settles Dec 3
  8. Nov 3, 202613d ago 8-K Bearish 5/10 Entry $15.95 Now $14.73 +7.65% settles Dec 3
  9. Nov 2, 202614d ago Insider Cluster Neutral 2/10 Entry $25.82 Now $14.73 −42.95% settles Dec 2
  10. Nov 2, 202614d ago 144 Neutral 2/10 Viewing Entry $25.82 Now $14.73 −42.95% settles Dec 2
Showing 10 of 33

US Market Status

Market Closed · Opens Wed (9h 40m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 2, 2026